home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Reusable Device Cleaning, Disinfection, and Sterilization Validations: Overview and Key Design Considerations for Device Engineers - Webinar By GlobalCompliancePanel

 
  January 05, 2012  
     
 
GlobalCompliancePanel, Online Training
2012-02-22


Validation of reusable medical devices requires that the manufacturer develop methods for cleaning (after use) washing to remove all foreign matter possibly disinfecting and repackaging for the next use. 

The diversity of medical devices their intended use and classification in accordance with the food and drug administration requires that the manufacturer develop and validate the reprocessing of the medical device. 

Reprocessing usually entails that the manufacturers thoroughly understand the design of the device and what potential hazards can occur if the device is not properly cleaned before reprocessing. This usually means that the manufacturer must establish clear and efficacious instructions on how to reprocess the medical device before reuse.

Why you should attend: To assist you in the identification of key factors during the development of your protocol. you will be guided on how to identify  key factors in the protocol  design process. Key factors such as selection of chemical agents specifically biocidal agents and or biostatic agent(s). Identify testing that will be required to evaluate these proposed agents
 
Biocompatibility issues, such as should you test for cytotoxicity, tolerable contact limit (TCL) as stated in ISO 10993-7.

If you require sterilization of your reusable should packaging and penetration issues be addressed.  What will be the required sterility specifications for your product. Sterility assurance issues will be discussed.

 

You will be able to write and review medical device reprocessing protocols and assists in the revision process, in order to eliminate or minimize process interruptions.

Areas Covered In the Session: 
  • Key points regarding protocol development
  • A summary of standards
  • Key tests to be familiar with
  • Expected results
  • Packaging issues
  • Labeling issues
  •  
 Who will benefit:  
  • Engineering
  • Quality
  • Validation
  • Microbiology
  • Process/ Scientist
  • Manufacturing
  • Regulatory Affairs
Price List:
Live : $245.00
Corporate live : $995.00
Recorded : $295.00


 
 
Organized by: GlobalCompliancePanel
Invited Speakers:
Rudy Pina has over 30 years of experience in The Medical Device Industry. He has worked for American Hospital Supply, Baxter Healthcare. Rudy is President of Dynatec Scientific Laboratories Inc. Rudy is a member of the Association for the Advancement of Medical Instrumentation (AAMI) Sterilization Working Group. Member of FDA/Industry Coolition - Dallas District Office Member of NAFTA - Trilateral Negotiations - Medical Technology Sector.
 
Deadline for Abstracts: 2012-02-21
 
Registration:
webinars@globalcompliancepanel.com
http://www.globalcompliancepanel.com

Phone: 800-447-9407
Fax: 302-288-6884
E-mail: globalcompliancepanel@gmail.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.